Chengdu Easton Biopharmaceuticals Co Ltd Asset Resilience Ratio

Latest as of June 2026: 35.16%

Chengdu Easton Biopharmaceuticals Co Ltd asset resilience ratio. Chengdu Easton Biopharmaceuticals Co Ltd (688513) has an Asset Resilience Ratio of 35.16% as of June 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See Chengdu Easton Biopharmaceuticals Co Ltd (688513) liquidity interval to measure how many days the company can operate on defensive assets alone.

Liquid Assets

CN¥1.34 Billion

≈ $196.75 Million USD Cash + Short-term Investments

Total Assets

CN¥3.82 Billion

≈ $559.60 Million USD All company assets

Resilience Assessment

Very High

Financial Resilience Level

Asset Resilience Ratio of Chengdu Easton Biopharmaceuticals Co Ltd (2013–2025)

Asset resilience ratio of Chengdu Easton Biopharmaceuticals Co Ltd from 2013 to 2025. This chart shows how Chengdu Easton Biopharmaceuticals Co Ltd's Asset Resilience Ratio has changed over time. Read Chengdu Easton Biopharmaceuticals Co Ltd (688513) financial obligations for a breakdown of total debt and financial obligations.

Liquid Assets Composition Over Time

This chart breaks down Chengdu Easton Biopharmaceuticals Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see how large is Chengdu Easton Biopharmaceuticals Co Ltd's balance sheet.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥1.34 Billion	35.16%
Total Liquid Assets	CN¥1.34 Billion	35.16%

Asset Resilience Insights

Very High Liquidity: Chengdu Easton Biopharmaceuticals Co Ltd maintains exceptional liquid asset reserves at 35.16% of total assets.
This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
The company has significant short-term investments, indicating active treasury management.

Chengdu Easton Biopharmaceuticals Co Ltd Industry Peers by Asset Resilience Ratio

Compare Chengdu Easton Biopharmaceuticals Co Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
argenx NV ADR NASDAQ:ARGX	Biotechnology	15.95%
Tubize-Fin BR:TUB	Biotechnology	2.50%
Ascendis Pharma AS NASDAQ:ASND	Biotechnology	0.00%
Summit Therapeutics PLC NASDAQ:SMMT	Biotechnology	36.07%
Madrigal Pharmaceuticals Inc NASDAQ:MDGL	Biotechnology	62.31%
Biomarin Pharmaceutical Inc NASDAQ:BMRN	Biotechnology	0.00%
Verona Pharma PLC ADR NASDAQ:VRNA	Biotechnology	0.00%
3SBio Inc F:83B	Biotechnology	10.64%

Chengdu Easton Biopharmaceuticals Co Ltd Asset Resilience Ratio by Year (2013–2025)

Chengdu Easton Biopharmaceuticals Co Ltd asset resilience ratio by year from 2013 to 2025. The table below shows the annual Asset Resilience Ratio data for Chengdu Easton Biopharmaceuticals Co Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-12-31	19.96%	CN¥758.00 Million ≈ $110.92 Million	CN¥3.80 Billion ≈ $555.75 Million	+6.65pp
2024-12-31	13.30%	CN¥452.35 Million ≈ $66.19 Million	CN¥3.40 Billion ≈ $497.55 Million	-8.86pp
2023-12-31	22.16%	CN¥741.78 Million ≈ $108.55 Million	CN¥3.35 Billion ≈ $489.74 Million	+5.05pp
2022-12-31	17.11%	CN¥516.36 Million ≈ $75.56 Million	CN¥3.02 Billion ≈ $441.56 Million	+0.76pp
2021-12-31	16.35%	CN¥453.84 Million ≈ $66.41 Million	CN¥2.78 Billion ≈ $406.11 Million	-6.17pp
2020-12-31	22.52%	CN¥570.00 Million ≈ $83.41 Million	CN¥2.53 Billion ≈ $370.34 Million	+21.34pp
2013-12-31	1.18%	CN¥3.00 Million ≈ $438.99K	CN¥254.86 Million ≈ $37.29 Million	--

pp = percentage points

About Chengdu Easton Biopharmaceuticals Co Ltd

SHG:688513 China Biotechnology

Market Cap

$1.08 Billion

CN¥7.39 Billion CNY

Market Cap Rank

#8268 Global

#1880 in China

Share Price

CN¥41.85

Change (1 day)

-1.23%

52-Week Range

CN¥40.68 - CN¥79.60

All Time High

CN¥79.60